Skip to main content

Table 3 Treatment completion by co-morbid Axis I Disorder

From: Participation in a novel treatment component during residential substance use treatment is associated with improved outcome: a pilot study

  RRTP-CP NR-Horticulture NR-Art/Music
  Total Participants (n) Completed Treatment % Total Participants (n) Completed Treatment % p-value Total Participants (n) Completed Treatment % p-value
Substance-Induced Disorders 12 75 0 n/a n/a 0 n/a n/a
Dementia, Cognitive Disorder 3 100 0 n/a n/a 0 n/a n/a
Schizophrenia, Schizoaffective 15 60 3 100 0.00 3 100 0.18
Major Depression 37 68 16 81 0.31 3 100 0.24
Bipolar I, II 31 58 9 67 0.64 5 80 0.35
Bipolar NOS & Mood Disorder NOS 23 61 3 67 0.36 4 100 0.13
Malingering 3 100 2 100 n/a 1 100  
Anxiety Disorders 14 64 4 75 0.69 1 100 0.47
Dysthymic Disorder  21 52 3 67 0.54 1 100 0.35
Depression NOS  102 71 17 81 0.00 9 55 0.35
Attention Deficit Disorder  4 50 4 100 0.10 1 100 0.36
Adjustment Disorder  7 29 2 100 0.07 0 n/a n/a
All Other Axis I Diagnoses  5 60 0 n/a n/a 0 n/a n/a
Total with co-morbid disorders 277 65 63 79 0.02 25 72 0.49
Total with no co-morbid disorder 235 80 37 87 0.35 5 80 1.00